Skip to contentUniversity of Michigan Health System - link
Department of Internal Medicine - link
INFECTIOUS DISEASES
search this site
 

About Us



Info for Patients




Referring Physicians




Our Faculty




Education & Research



HIV/AIDS Treatment Program




More News




Internal Resources




Internal Medicine Divisions

 
Dr. Tejal Gandhi

Description of Research: Tejal Gandhi

HIV/AIDS

Dr. Gandhi is a member of the HIV/AIDS Treatment Program and completed additional training specifically in this area. Research interests include the impact of incompletely suppressive antiretroviral (ARV) regimens on opportunistic infection (OI) rates, immunologic outcomes, virologic outcomes, and occurrence of drug resistant mutations in patients with highly drug resistant HIV. We have found that maintaining an incompletely suppressive ARV regimen reduces OI rates and maintains a durable virologic and immunologic response in many patients. In addition, we have also found that patients with highly drug resistant HIV continue to acquire new drug resistant mutations while on a failing ARV regimen.

Antimicrobial Stewardship

Dr. Gandhi is a member of the Antimicrobial Stewardship Program for the hospital. The goal of our program is to ensure effective and appropriate utilization of antimicrobials for hospitalized patients, while minimizing unintended consequences of antimicrobial use (c.diff infection, selection of drug resistant pathogens, and drug toxicities). In addition, we participate in the development of evidence based guidelines for antimicrobial use. Research interests include the diagnosis and management of urinary tract infections in hospitalized patients.


Recent Publications

Gandhi T, Wei W, Amin K, Kazanjian P. Effect of Maintaining HAART on AIDS Events in Late Stage HIV Infected Patients with Inadequate CD4 and Viral Responses. Clin Infect Dis 2006;42: 878-84

Gandhi T, Nagappan V, Cinti S, Wei W, Kazanjian P. Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive Antiretroviral regimen. Clin Infect Dis 45 (8): 1085-1092, 2007.

Cinti, SK; Gandhi, T; Riddell, J. Non-AIDS-defining cancers: Should antiretroviral therapy be initiated earlier? AIDS Read 18 (1): 18, 2008.

Gandhi T, Wu AH, Aronoff DM. Severe transient cardiomyopathy associated with community-acquired pneumonia caused by Streptococcus pneumoniae. Heart Lung 37 (5): 394-397, 2008.

Gandhi T, Flanders SA, Markovitz E, Saint S, Kaul DR. Importance of Urinary Tract Infection to Antibiotic Use Among Hospitalized Patients. Infect Contr Hosp Epidemiol 30 (2): 193-195, 2009.

Gandhi TN, DePestel DD, Collins CD, Nagel J, Washer LL. Managing antimicrobial resistance in intensive care units. Crit Care Med 38 (8): S315-S323 Suppl. S, 2010.


 
   
   

U-M Medical School
| Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright Regents of the University of Michigan
Template developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

 
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement

UMHS HOME

Health Topics A-Z

For Patients & Families

For Health Professionals

Search Tools & Index